Are peptides legal in the US? FDA, FTC, and DEA framework explained
Research-use-only peptides in the United States sit in a multi-layer regulatory grey zone. The FDA regulates drugs sold for human use under the Food, Drug, and Cosmetic Act (FDCA); the FTC polices product claims under Section 5 of the FTC Act; the DEA schedules compounds when their pharmacology warrants control. Most research peptides are not approved drugs, not scheduled controlled substances, and not legally sellable for human consumption. They are sold as research chemicals labelled "for laboratory research, not for human use" — a label that has both kept the segment alive and triggered enforcement when vendors crossed into therapeutic claims.
The FDA jurisdiction starts the moment a peptide is sold or marketed for use in or on the human body. A vendor who sells "BPC-157, 5 mg, for research use only" is generally outside FDA enforcement priority — the labelling matches the regulatory category. A vendor who sells the same vial with a website headline that promises faster injury recovery has crossed into making a drug claim about an unapproved drug, which is an FDCA violation. The FDA tracks the second category and issues warning letters; the most recent significant enforcement against a peptide vendor was the June 2025 raid of Amino Asylum, which had been advertising peptides with explicit therapeutic positioning. Amino Asylum is offline as of this writing.
The FTC operates parallel to the FDA on the marketing side. FTC Endorsement Guides (16 CFR Part 255) require disclosed material connections — affiliates who recommend peptides without disclosing that they earn commission are technically in violation. The FTC has not pursued peptide-specific endorsement cases at scale, but the legal exposure exists. PeptideGuide discloses every affiliate relationship on the [/disclosures](/disclosures) page; vendors and reviewers who do not disclose are operating under FTC risk.
The DEA regulates compounds that meet the Controlled Substances Act criteria — abuse potential, dependence liability, accepted medical use. Most research peptides do not meet these criteria and are not scheduled. SARMs (selective androgen receptor modulators) are sometimes scheduled at the state level but not federally; some hormone analogues like 2,4-DNP are listed but are not commonly sold by peptide vendors. Researchers should verify the current schedule status of any specific compound at the time of order.
State law layers on top. California Proposition 65 requires warnings when products contain compounds known to the state to cause cancer or reproductive harm — several peptide synthesis precursors fall under this. New York and several other states have their own labelling and disclosure rules. The federal "research-use-only" framing does not exempt vendors from state-level consumer-protection law.
Two recent market events are worth orienting around. Amino Asylum (June 2025) was raided by the FDA and remains offline; the enforcement followed years of marketing language that crossed into therapeutic-claim territory. Peptide Sciences voluntarily shut down on 2026-03-06 — the operator cited "regulatory pressure" without specifying the exact agency action; their site now redirects to a notice. Both events confirm that the FDA enforcement priority correlates strongly with marketing tone, not the molecule itself: the same compound can be sold legally with a "research use only" label and illegally with a "treats injuries" claim.
For US-based researchers, the practical implication is conservative selection: vendors who maintain strict research-use-only labelling, ship with COAs, disclose third-party testing labs, and avoid therapeutic claims have the lowest legal exposure on the buyer side. Vendors who advertise peptides as wellness products, supplement-adjacent compounds, or with implicit health claims carry higher exposure for the seller and pull the regulatory spotlight onto the segment.
The PeptideGuide methodology weights "trust history" as 20% of the composite score and explicitly considers FDA / FTC enforcement signals: a vendor with a recent warning letter or a documented marketing-claim incident drops in the trust axis. The full scoring rubric is published on [/methodology](/methodology).
✓Pros
- Multiple compliant vendors operate openly in the US (Core Peptides, Umbrella Labs, Biotech Peptides, Peptide Pros)
- Domestic shipping is fast (2–5 business days) with no customs exposure
- USD pricing — no FX conversion friction
- Federal-level "research-use-only" framing is well-established and stable
×Cons
- State-level law (Prop 65, NY disclosure) varies and can layer on top of federal compliance
- FDA enforcement priority correlates with marketing tone — vendors who use therapeutic claims are at risk and so are their funnels
- SARMs / peptide overlap is sharper than EU; vendors who sell both attract more regulatory attention
- Recent shutdowns (Amino Asylum, Peptide Sciences) show the segment is enforcement-active
Is it legal to buy research peptides in the United States?
Yes, when both the vendor and the buyer treat them as research chemicals — labelled "for laboratory research, not for human use" and not marketed with therapeutic claims. The FDA does not approve research peptides as drugs; the DEA generally does not schedule them. Buying for verified research purposes from a compliant vendor is not illegal under federal law.
Can I be prosecuted for ordering peptides for personal use?
Federal prosecution of individual buyers for personal-use research peptide orders is rare. FDA and FTC enforcement targets vendors and large-scale resellers, not end buyers. State law varies — some states have aggressive consumer-protection postures. PeptideGuide does not encourage personal-use orders and does not provide individual legal advice.
Why was Amino Asylum raided by the FDA?
Amino Asylum was raided in June 2025 after sustained marketing that crossed into therapeutic-claim language — using language that suggested its peptides treated specific conditions. The FDA enforcement priority for unapproved drug claims is well-documented; the raid followed the standard pattern of warning-letter then enforcement when claims persisted. Amino Asylum is offline as of this writing.
What does "research-use only" actually mean legally?
It is the regulatory category that distinguishes a research chemical from an unapproved drug. A research chemical is sold for laboratory or scientific use, not for direct administration to humans. The label "for laboratory research, not for human use" is the explicit signal that places a vendor in this category. Vendors who use the label but market the product for human use are not protected by it — the FDA evaluates marketing tone, not just the label text.
Are SARMs the same as peptides under US law?
No. SARMs (Ostarine, RAD-140, LGD-4033, etc.) are selective androgen receptor modulators — small-molecule drugs that act on the androgen receptor. Peptides are short amino-acid chains. The two are sometimes co-sold by the same vendors but have different regulatory statuses: some SARMs have been scheduled at state level (California, etc) while most research peptides are not scheduled anywhere. Buying a SARM in a state where it is scheduled is illegal; buying a research peptide in those same states usually is not.
Does FDA enforcement extend to affiliate sites that recommend peptides?
In principle yes — under FTC Endorsement Guides (16 CFR Part 255). An affiliate who recommends a peptide without disclosing the affiliate relationship is in technical violation; an affiliate who makes therapeutic claims about peptides is in stronger violation. The FTC has not pursued peptide-specific endorsement cases at scale, but the exposure exists. PeptideGuide discloses every affiliate relationship at [/disclosures](/disclosures).
What about Peptide Sciences shutting down in March 2026?
Peptide Sciences voluntarily shut down on 2026-03-06 with a brief notice citing "regulatory pressure." The operator did not specify the exact agency action; the site now redirects. The shutdown is consistent with the broader pattern: vendors that maintained strict research-use-only labelling and avoided therapeutic claims have continued operating; vendors that drifted into therapeutic territory have either been raided (Amino Asylum) or chose to exit ahead of action.
Should I worry about US Customs intercepting research peptide orders?
Domestic US-to-US orders involve no Customs at all — the order is shipped via USPS, UPS, or FedEx within the country. International orders into the US can be interception-prone, but most US researchers order from US-domestic vendors (Core Peptides, Umbrella Labs, etc) and avoid the Customs question entirely.